Characteristics of the sequence effect in Parkinson's disease
- PMID: 20669182
- PMCID: PMC4782591
- DOI: 10.1002/mds.23251
Characteristics of the sequence effect in Parkinson's disease
Abstract
The sequence effect (SE) in Parkinson's disease (PD) is progressive slowing of sequential movements. It is a feature of bradykinesia, but is separate from a general slowness without deterioration over time. It is commonly seen in PD, but its physiology is unclear. We measured general slowness and the SE separately with a computer-based, modified Purdue pegboard in 11 patients with advanced PD. We conducted a placebo-controlled, four-way crossover study to learn whether levodopa and repetitive transcranial magnetic stimulation (rTMS) could improve general slowness or the SE. We also examined the correlation between the SE and clinical fatigue. Levodopa alone and rTMS alone improved general slowness, but rTMS showed no additive effect on levodopa. Levodopa alone, rTMS alone, and their combination did not alleviate the SE. There was no correlation between the SE and fatigue. This study suggests that dopaminergic dysfunction and abnormal motor cortex excitability are not the relevant mechanisms for the SE. Additionally, the SE is not a component of clinical fatigue. Further work is needed to establish the physiology and clinical relevance of the SE. © 2010 Movement Disorder Society.
Figures




Similar articles
-
Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.Mov Disord. 2009 Apr 15;24(5):672-6. doi: 10.1002/mds.22417. Mov Disord. 2009. PMID: 19185021 Clinical Trial.
-
Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease.J Clin Neurosci. 2014 Aug;21(8):1373-6. doi: 10.1016/j.jocn.2013.11.025. Epub 2014 Mar 13. J Clin Neurosci. 2014. PMID: 24631324 Clinical Trial.
-
Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.Mov Disord. 2009 Jan 30;24(2):246-53. doi: 10.1002/mds.22348. Mov Disord. 2009. PMID: 18951540 Clinical Trial.
-
Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.Neuroscience. 2008 Dec 10;157(4):798-812. doi: 10.1016/j.neuroscience.2008.09.051. Epub 2008 Oct 4. Neuroscience. 2008. PMID: 18952153 Clinical Trial.
-
Does levodopa slow or hasten the rate of progression of Parkinson's disease?J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. doi: 10.1007/s00415-005-4008-5. J Neurol. 2005. PMID: 16222436 Review.
Cited by
-
Video analysis reveals early signs of Bradykinesia in REM sleep behavior disorder and Parkinson's disease.NPJ Parkinsons Dis. 2025 Jul 30;11(1):222. doi: 10.1038/s41531-025-01082-0. NPJ Parkinsons Dis. 2025. PMID: 40739299 Free PMC article.
-
Effect of different modalities of transcranial magnetic stimulation on Parkinson's patients cognitive impairment and long-term effectiveness: a systematic review and network meta-analysis.Front Neurosci. 2024 Mar 1;18:1354864. doi: 10.3389/fnins.2024.1354864. eCollection 2024. Front Neurosci. 2024. PMID: 38495111 Free PMC article.
-
Redefining Bradykinesia.Mov Disord. 2023 Apr;38(4):551-557. doi: 10.1002/mds.29362. Epub 2023 Feb 27. Mov Disord. 2023. PMID: 36847357 Free PMC article. No abstract available.
-
Differential components of bradykinesia in Parkinson's disease revealed by deep brain stimulation.J Neurophysiol. 2024 Sep 1;132(3):870-878. doi: 10.1152/jn.00320.2022. Epub 2024 Jul 10. J Neurophysiol. 2024. PMID: 38985938
-
Novel insights into the effects of levodopa on the up- and downstrokes of writing sequences.J Neural Transm (Vienna). 2022 Apr;129(4):379-386. doi: 10.1007/s00702-022-02493-6. Epub 2022 Mar 31. J Neural Transm (Vienna). 2022. PMID: 35357564
References
-
- Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson’s disease. Brain. 2001;124:2131–2146. - PubMed
-
- Evarts EV, Teravainen H, Calne DB. Reaction time in Parkinson’s disease. Brain. 1981;104:167–186. - PubMed
-
- Velasco F, Velasco M. A quantitative evaluation of the effects of L-dopa on Parkinson’s disease. Neuropharmacology. 1973;12:89–99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical